Handheld cellular telephone use not associated with risk of brain cancer

December 18, 2000

Study suggests risk not increased with short-term cell phone use

CHICAGO -- The use of handheld cellular telephones does not appear to be associated with the risk of brain cancer, but further studies are needed to account for longer induction periods, especially for slow-growing tumors, according to an article in the December 20 issue of The Journal of the American Medical Association (JAMA).

Joshua E. Muscat, M.P.H., of the American Health Foundation, Valhalla, N.Y., and colleagues conducted a case-control study from 1994 to 1998 to test the hypothesis that using handheld cellular telephones is related to the risk of primary brain cancer. A total of 469 men and women aged 18 to 80 with primary brain cancer and 422 matched controls without brain cancer took part in the study. Patients were interviewed at Memorial Sloan-Kettering Cancer Center, New York University Medical Center, and Columbia Presbyterian Hospital in New York; Rhode Island Hospital in Providence, R.I.; and Massachusetts General Hospital in Boston.

According to background information cited in the study, there were more than 86 million cellular phone users by the end of 1999. The use of cellular telephones is one of several suspected risk factors for brain cancer, although the causes of this disease remain poorly understood. The health effects due to using cellular telephones are currently being studied in a number of populations. In preliminary reports of a case-control study conducted in Sweden, the risk of brain cancer was unrelated to using a handheld cellular telephone.

Cellular telephones include handheld or mobile telephones, car telephones, and portable or bag telephones that operate on radiofrequency (RF) signals in the 800- to 900-MHz range. Concerns have been raised about possible adverse health effects due to exposure to these signals. In particular, the concern that the use of handheld cellular telephones causes brain cancer is based on the close proximity of the antenna, which is incorporated into the telephone receiver, to the head of the user.

The authors used a structured questionnaire to interview patients. The patients were asked if they had ever used a handheld cellular telephone on a regular basis. "Regular" was defined as having had a subscription to cellular telephone service. Information was obtained on the number of years of use, minutes/hours used per month, year of first use, manufacturer, and reported average monthly bill. Information on which hand was used to hold the cellular telephone was collected from 700 (78.6 percent) of the 891 patients.

"The use of handheld cellular telephones was unrelated to the risk of brain cancer in the current study," the authors write.

"The median monthly hours of use were 2.5 for cases and 2.2 for controls," they report. "Compared with patients who never used handheld cellular telephones, the multivariate odds ratio (OR) associated with regular past or current use was 0.85. The OR for infrequent users (less than 0.72 hours per month) was 1.0 and for frequent users (more than 10.1 hours per month) was 0.7."

"The mean duration of use was 2.8 years for cases and 2.7 years for controls; no association with brain cancer was observed according to duration of use," they continue.

The study found that among brain cancer cases, cerebral tumors occurred more frequently on the same side of the head where cellular telephones had been used (26 vs. 15 cases). But in cases of temporal lobe cancer, a greater proportion of tumors occurred in the opposite side of the head (9 vs. 5 cases).

The authors report the odds ratio was less than 1.0 (i.e., no increase in risk) for all histologic categories of brain cancer except for an uncommon type of brain cancer called neuroepitheliomatous.

"The current study shows no effect with short-term exposure to cellular telephones that operate on (primarily) analog signals," the authors conclude. "Further studies are needed to account for longer induction periods, especially for slow-growing tumors. The RF fields emitted from digital cellular telephones might have different effects on biological tissue than analog telephones, and studies are under way in several European countries that use primarily digital telecommunication networks." (JAMA. 2000; 284:3001-3007)
-end-
Editor's Note: This work was supported by a contract from Wireless Technology Research LLC and by grants from the Public Health Service.

This release is reproduced verbatim and with permission from the American Medical Association as a service to reporters interested in health and behavioral change. For more information about The Journal of the American Medical Association or to obtain a copy of the study, please contact the American Medical Association's Science News Department at (312) 464-5374.

Posted by the Center for the Advancement of Health . For more research news and information, go to our special section devoted to health and behavior in the "Peer-Reviewed Journals" area of Eurekalert!, http://www.eurekalert.org/restricted/reporters/journals/cfah/. For information about the Center, call Petrina Chong, pchong@cfah.org (202) 387-2829.

Center for Advancing Health

Related Brain Cancer Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Cancer cells mediate immune suppression in the brain
Notre Dame researchers showed that one type of cell important for immunity, called a myeloid cell, can suppress the immune response -- which has the effect of allowing breast cancer cells to metastasize to the brain to form secondary tumor cells there.

New therapy targets breast cancer metastases in brain
When breast cancer spreads to the brain, the prognosis is grim.

AI may help brain cancer patients avoid biopsy
Brain cancer patients in the coming years may not need to go under the knife to help doctors determine the best treatment for their tumors.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Finding new clues to brain cancer treatment
Researchers at Case Western Reserve University School of Medicine and Cleveland Clinic new discovered a more accurate way to determine the relative life expectancy of glioblastoma victims and identify who could be candidates for experimental clinical drug trials by blending information from Artificial Intelligence (AI)--in this case, computer image analysis of the initial MRI scans taken of brain cancer patients--and genomic research.

Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain
Effective drug delivery through the BTB is one of the greatest therapeutic obstacles in treating brain metastases.

Blood test could help to accelerate brain cancer diagnosis
A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of Strathclyde.

The 'Goldilocks' principle for curing brain cancer
University of Minnesota Medical School researchers found that a stable body temperature holds the key to awakening the body's immune response to fight off brain cancer.

The path of breast-to-brain cancer metastasis
Scientists at EPFL's Swiss Institute for Experimental Cancer Research have discovered a signaling pathway that breast tumors exploit to metastasize to the brain.

Read More: Brain Cancer News and Brain Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.